Skip to content

Ayurveda for Flu Like Illness During Covid-19 Outbreak

Ayurveda for Flu-like Illness During the Covid 19 Outbreak: Non Randomised Single-blind Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04351542
Enrollment
32
Registered
2020-04-17
Start date
2020-03-06
Completion date
2020-04-12
Last updated
2020-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Flu Like Illness

Brief summary

This study aimed to evaluate the efficacy and safety of Ayurveda in reducing symptoms of flu like illness during the Covid 19 outbreak.

Interventions

DIETARY_SUPPLEMENTAyurveda

Based on individual constitution (ayurveda based assessment) and symptoms an individual has, ayurveda herbal supplement and self managed practices were advised along with usual care recommendation.

OTHERUsual Care

Usual care recommended by National Health Services, self isolation, plenty fluid, rest and Paracetamol. During the Covid 19 outbreak, additional recommendation were followed given by health services.

Sponsors

Aarogyam UK
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Caregiver)

Masking description

Ayurveda care provide was blinded

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Patients with fu like symptoms within 48 hours of onset during March2020 * Mild to moderate symptoms who were advised to self isolate at home for 7-14 days * Flu like symptoms present at least one respiratory symptom (e.g. cough, nasal obstruction, sore throat) and at least one constitutional symptom other than fever (e.g. fatigue, headache, myalgias) of less than 48-hour duration * Willing to consent and follow up

Exclusion criteria

* Pregnant/lactating * Participants with chronic pulmonary diseases or critical condition or already developed severe respiratory distress * Clinically malignancies, systemic infection, other medical or psychiatric condition which places the subject at unacceptable risk to participate in the study - Known hypersensitivity to any ayurveda herbal substances * Severe symptoms of respiratory distress patients deemed to require intensive care immediately

Design outcomes

Primary

MeasureTime frameDescription
Time to achieve afebrileChange from baseline to 3rd and 7th-dayTime to bring down a fever (oral temperature \< 37.2 ̊C)
Severity of symptom scoreChange from baseline to 3rd and 7th daySymptoms diary card completed twice daily from Day 0 to Day 7

Secondary

MeasureTime frameDescription
Patient reported improvementChange from baseline to 3rd and 7th-dayPatient reported improvement using 4 scale; 0-none, 1-weak, 2-medium, 3-strong

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026